PMA P050047S077

Device
Juvéderm Ultra, Ultra XC, Ultra Plus, and Ultra Plus XC
Applicant
Allergan
PMA number
P050047
Supplement
S077
Product code
LMH
Decision date
2020-07-17
Generic name
Implant, dermal, for aesthetic use
Approval order statement
Approval for revisions to the clinician labeling of Juvéderm® Ultra, Juvéderm® Ultra XC, Juvéderm® Ultra Plus, Juvéderm® Ultra Plus XC, Juvéderm® Vollure XC, and Juvéderm® Volbella XC to include updated safety information based on post marketing surveillance data

Current openFDA PMA Record#

Device
Juvéderm Ultra, Ultra XC, Ultra Plus, and Ultra Plus XC
Applicant
Allergan
PMA number
P050047
Supplement
S077
Product code
LMH
Generic name
Implant, dermal, for aesthetic use
Decision date
2020-07-17
Decision code
APPR
Date received
2020-06-19
Supplement type
Special (Immediate Track)
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Approval order statement
Approval for revisions to the clinician labeling of Juvéderm® Ultra, Juvéderm® Ultra XC, Juvéderm® Ultra Plus, Juvéderm® Ultra Plus XC, Juvéderm® Vollure XC, and Juvéderm® Volbella XC to include updated safety information based on post marketing surveillance data